Bill
HRES 342
Overview: HRES 342, Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes, Submitted in House, Introduced: April 21, 2025Purpose
Overview: HRES 342, Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes, Submitted in House, Introduced: April 21, 2025
Purpose and Intent: The purpose of this resolution is to recognize the history and harmful impacts of the drug diethylstilbestrol (DES), a synthetic estrogen that was widely prescribed to pregnant women in the mid-20th century.
Key Provisions:
- Acknowledges the significant health problems and adverse effects experienced by individuals exposed to DES, including increased risks of certain cancers, reproductive issues, and other medical conditions
- Expresses the sense of the House of Representatives regarding the need to continue research, education, and support for those affected by DES exposure
- Calls for increased awareness and understanding of the DES tragedy and its lasting impacts
Affected Parties and Impacts:
- Individuals who were exposed to DES, either in utero or through other means, and their families
- Healthcare providers and researchers focused on DES-related health issues
- The general public, through increased awareness and understanding of the DES tragedy
Procedural and Timeline Considerations:
- This resolution has been submitted in the House of Representatives and is currently under consideration
- If passed, the resolution would express the sense of the House regarding the history and impacts of DES, but would not have the force of law
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
